|
|
|
|
|
by superkuh
448 days ago
|
|
The nervous system damage like that is certainly a big concern. Especially with the adjacency of the mucosal tissues of the sinuses, etc, to the central nervous system proper. And then there's the problem that intramuscular sars-cov-2 vaccination has basically zero measurable effect on long-covid syndrome(s). I really just wanted my entire body to be protected before being infected and the viral load as low as possible during infection. >folks making their own intranasal vaccines with research peptides I wish the RaDVaC were still available, but around the time of sars-cov-2 delta(?) they were no longer able manufacture the proteins needed for their intranasal protein vaccination (they tried but they could not produce it; a common problem with full protein vaccines). It hasn't been an option for quite a while. The only real option would be a medical tourism trip to India to get their iNCOVACC intranasal sars-cov-2 vaccine but I do not think I have the money or ability to successfully navigate a foreign medical system. |
|